Journal of the Korean Ophthalmological Society 2002;43(7):1310-1322.
Published online July 1, 2002.
Study on Fibrovascular Ingrowth into the Intraocular Implant, Medpor(R).
Sung Guan Soe, Young Il Kim, Sung Gyun Shin, Boo Sup Oum
1Department of Ophthalmology, Busan Paik Hospital, The Inje University Medical College, Korea. seossg@hanmail.net
2Shin & Park eye clinic, Korea.
3Department of Ophthalmology, College of medicine, Busan national University, Korea.
Medpor(R) 내로의 섬유혈관화에 대한 연구
서성관 ( Sung Guan Soe ) , 김영일 ( Young Il Kim ) , 신성균 ( Sung Gyun Shin ) , 엄부섭 ( Boo Sup Oum )
Abstract
PURPOSE
We investigated the effects of bFGF/Sucralfate/Hydron suspension and hyperbaric oxygen on fibrovascular ingrowth into porous implants materials. METHODS: Eight rabbits underwent bilateral abdominal incision through which porous orbital disc-shaped implants were inserted between abdominal muscles. These implants were either uncoated or coated with suspension of bFGF/Sucralfate/Hydron. Hyperbaric oxygen therapy was performed on 4 selected rabbits for 5 days or 10 days. Implants were harvested after 3 days, 1 week, 2 weeks and 4 weeks. RESULTS: Enhanced fibrovascular ingrowth was shown in bFGF/Sucralfate/Hydron or hyperbaric oxygen treated implants. bFGF/Sucralfate/Hydron treated implants demonstrated more fibrovascularization than hyperbaric oxygen treated implants. CONCLUSIONS: Simultaneous therapy of bFGF/Sucralfate/Hydron and hyperbaric oxygen showed more fibrovascularization than separately treated implants.
Key Words: Basic fibroblast growth factor;Fibrovascular ingrowth;Hyperbaric oxygen therapy;polyethylene (Medpor(R)) implants


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2024 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next